The fully human anti-GPRC5D CAR T-cell therapy RD118 induces durable remissions in relapsed/refractory multiple myeloma.
- DOI
- 10.1182/blood.2025030559
- Published
- 2026-01-01
- Container
- Blood
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/blood.2025030559,
title = {The fully human anti-GPRC5D CAR T-cell therapy RD118 induces durable remissions in relapsed/refractory multiple myeloma.},
author = {Pan M and Wang D and Xu J and Jin S and Wang Y and Tao Y and Liu Y and Ouyang W and Weng X and Yi H and Huang Y and Cao X and Li S and Zhang F and Zhang W and Li C and Mi JQ.},
year = {2026},
journal = {Blood},
doi = {10.1182/blood.2025030559},
url = {https://doi.org/10.1182/blood.2025030559}
}RIS
TY - JOUR TI - The fully human anti-GPRC5D CAR T-cell therapy RD118 induces durable remissions in relapsed/refractory multiple myeloma. AU - Pan M AU - Wang D AU - Xu J AU - Jin S AU - Wang Y AU - Tao Y AU - Liu Y AU - Ouyang W AU - Weng X AU - Yi H AU - Huang Y AU - Cao X AU - Li S AU - Zhang F AU - Zhang W AU - Li C AU - Mi JQ. PY - 2026 JO - Blood DO - 10.1182/blood.2025030559 UR - https://doi.org/10.1182/blood.2025030559 ER -
APA
M, P., D, W., J, X., S, J., Y, W., Y, T., Y, L., W, O., X, W., H, Y., Y, H., X, C., S, L., F, Z., W, Z., C, L., & JQ., M. (2026). The fully human anti-GPRC5D CAR T-cell therapy RD118 induces durable remissions in relapsed/refractory multiple myeloma.. Blood. https://doi.org/10.1182/blood.2025030559
Source records
- europe-pmc · retrieved 2026-09-27T04:07:56.394Z